Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MARAbio logo — Our vision is a world in which the most severe effects of au...

MARAbio

Our vision is a world in which the most severe effects of autism do not occur.

Founded 2016 United States Salt Lake City, United States 14 employees Venture round Biotechnology

General Information

Company Name MARAbio
Founded Year 2016
Location United States Salt Lake City, United States
Employees 14
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with MARAbio. To contact MARAbio, visit marabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MARAbio compare?

A PDF of MARAbio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MARAbio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MARAbio

MARAbio is a biotechnology startup founded in 2016 with the vision of mitigating the impact of autism. The company focuses on identifying the risk of developing Maternal Autoantibody Related Autism (MARA), a subtype of autism representing approximately 20% of overall cases. Their precision technology utilizes a blood test to detect a distinct cluster of autoantibodies associated with MARA, enabling early risk assessment for the development of autism in a child. MARAbio's innovative approach involves offering a new type of risk assessment test for prospective mothers before, but not during, pregnancy, as well as during the early postnatal period. The startup received a Venture Round investment on 01 January 2019 from the Autism Impact Fund and David Carrico. Based in the United States, MARAbio's mission is aligned with addressing a critical aspect of autism and providing families with options to reduce the occurrence or severity of MARA.

Taxonomy: Autism risk assessment, Maternal Autoantibody Related Autism, Precision technology, Blood test, Autoantibody cluster, Early risk assessment, Child development, Healthcare innovation, Medical diagnostics, Prenatal screening, Postnatal monitoring

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Autism Impact Fund
Autism Impact Fund, David Carrico
01 Jan 2019

MARAbio Alternatives & Competitors

View All Alternatives
MARAbio vs
Mirvie
Mirvie United States

Shaping the future of pregnancy health.

Grant
47 employees
Biotechnology, Health Care
MARAbio vs
Cleveland Diagnostics
Cleveland Diagnostics United States

Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of cancer detecti...

Private Equity
76 employees
Biotechnology, Health Care
MARAbio vs
BillionToOne
BillionToOne United States

We push the boundaries of molecular diagnostics through quantitative technologies.

IPO
815 employees
Biotechnology, Health Care
View all alternatives

FAQ About MARAbio

Our vision is a world in which the most severe effects of autism do not occur.
MARAbio was founded in 2016.
MARAbio is headquartered in Salt Lake City, United States.
MARAbio operates in Biotechnology. Its work centres on Autism risk assessment, Maternal Autoantibody Related Autism, Precision technology and Blood test.
MARAbio has approximately 14 employees.
MARAbio has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to MARAbio include Mirvie, Cleveland Diagnostics, BillionToOne, Mellitus, LLC, Predemtec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MARAbio and Mirvie are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MARAbio, https://bouncewatch.com/company/marabio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes